BMC Cancer

Table 7 Reference values and mean ± SE of the differential blood cell count

From: A novel cytosporone 3-Heptyl-4,6-dihydroxy-3H-isobenzofuran-1-one: synthesis; toxicological, apoptotic and immunomodulatory properties; and potentiation of mutagenic damage

Cell types	Reference values	Experimental groups
Cell types	Reference values	Group 1	Group 2	Group 3	Group 4	Group 5	Group 6	Group 7
Lymphocyte	55 – 95 %	46.80 ± 1.96^a,b	40.40 ± 3,21^b	57.60 ± 1.20^a	54.80 ± 1.42^a	41.60 ± 3.58^b	57.20 ± 4.81^a	NA
Neutrophil	10 – 40 %	48.80 ± 1.93^a,b	55.20 ± 1,68^b	35.40 ± 0.74^a	37.40 ± 1.47^a	52.60 ± 3.97^b	37.60 ± 5.11^a	NA
Monocyte	0.1 – 3.5 %	2.20 ± 0.73^b	2.40 ± 1.16^a,b	3.20 ± 0.58^a,b	5.80 ± 0.86^a	3.80 ± 0.73^a,b	3.20 ± 0.58^a,b	NA
Eosinophil	0 – 0.4 %	2.20 ± 0.58^a	1.80 ± 0.58^a	3.80 ± 0.58^a	1.80 ± 0.58^a	2.00 ± 0.54^a	1.80 ± 0.58^a	NA
Basophil	0 – 0.3 %	0.00 ± 0.00^a	0.20 ± 0.20^a	0.00 ± 0.00^a	0.20 ± 0.20^a	0.00 ± 0.00^a	0.20 ± 0.20^a	NA

SE: Standard error
Different letters indicate statistically significant differences (p < 0.05; ANOVA/Tukey)

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com